Crommelin, Daan J.A.

mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability

Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 1,566

Addressing the Cold Reality of mRNA Vaccine Stability

Crommelin, D. J. A., Anchordoquy, T. J., Volkin, D. B., Jiskoot, W., & Mastrobattista, E. (2021) · Journal of Pharmaceutical Sciences

SARS-CoV-2 and COVID-19 ResearchRNA Interference and Gene Delivery

Cited by 517

Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products

Carpenter, J. F., Randolph, T. W., Jiskoot, W., Crommelin, D. J. A., Middaugh, C. R., & Winter, G. (2010) · Journal of Pharmaceutical Sciences

Protein purification and stabilityBiosimilars and Bioanalytical Methods

Cited by 202

Stabilization of proteins in dry powder formulations using supercritical fluid technology

Jovanović, N., Bouchard, A., Hofland, G. W., Witkamp, G.-J., Crommelin, D. J. A., & Jiskoot, W. (2004) · Pharmaceutical Research

Phase Equilibria and ThermodynamicsProtein purification and stability

Cited by 111

Report of the AAPS Guidance Forum on the FDA draft guidance for industry:“drug products, including biological products, that contain nanomaterials”

de Vlieger, J. S. B., Crommelin, D. J. A., Tyner, K., Drummond, D. C., Jiang, W., McNeil, S. E., Neervannan, S., Crist, R. M., & Shah, V. P. (2019) · The AAPS Journal

Nanoparticle-Based Drug DeliveryPharmaceutical studies and practices

Cited by 100